Learn More
Description
CD154, clone 89-76, is derived from hybridization of mouse NS-1 cells with spleen cells from BALB/c mice immunized with sgp39-CD8 and activated human peripheral blood lymphocytes (PBLs).
CD154 (CD40 ligand or CD40L) recognizes a 39-kilodalton (kDa) antigen that is a member of the tumor necrosis factor (TNF) receptor family. CD154 is transiently expressed on activated CD4 T lymphocytes. The expression of CD154 by activated T-helper cells triggers B-cell cycling through binding to CD40. This co-receptor interaction is required for B-lymphocyte maturation, response to T-dependent ligands, and isotype switching. T-lymphocyte proliferation and generation of cytotoxic T lymphocytes (CTLs) is associated with the presence of CD154. Defects in the CD154 gene are associated with the X-linked hyper IgM syndrome.
Specifications
Specifications
| Antigen | CD154 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | 89-76 |
| Concentration | 12.5μg/mL |
| Conjugate | PE |
| Formulation | Phosphate buffered saline with gelatin and 0.1% sodium azide. |
| Host Species | Mouse |
| Immunogen | Activiate human peripheral blood lymphocytes (PBLs) |
| Quantity | 50 Tests |
| Show More |
Safety and Handling
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.